MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Korro Bio, Inc. (NASDAQ: KRRO)*
Organization & Developments: Korro Bio
Parents
Korro Bio, Inc. (NASDAQ: KRRO)*
Children
* Korro Bio was created to lead the field of RNA editing.
*Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
*Platform of single-base RNA edits to treat a range of diseases.
*The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues.
2024: Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
2024: Korro Bio: An Interesting Platform With A Very Long Horizon
2024: Korro Bio: Still Too Long To Go... Just Keep Watching For Now (Rating Upgrade)
2025: Korro lays off 20% of staff to fund genetic med trials, Novo Nordisk partnership
2025: Novo Nordisk focused on biotech deals for cardiometabolic indications
Jumps
Finance & Acquisitions: Korro Bio
Key People: Korro Bio